Cargando…

Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells

Regulatory T cells (Tregs) represent a subpopulation of CD4(+) T cells, which are essential for the maintenance of immunological tolerance. The absence or dysfunction of Tregs can lead to autoimmunity and allergies. The restoration of functional Tregs and/or Treg cell numbers represents a novel and...

Descripción completa

Detalles Bibliográficos
Autores principales:	König, Martin, Rharbaoui, Faiza, Aigner, Silke, Dälken, Benjamin, Schüttrumpf, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724712/ https://www.ncbi.nlm.nih.gov/pubmed/26834751 http://dx.doi.org/10.3389/fimmu.2016.00011

Ejemplares similares

High thioredoxin-1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody Tregalizumab
por: Heim, Katharina, et al.
Publicado: (2016)

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway
por: Helling, Bianca, et al.
Publicado: (2015)

Regulatory Approved Monoclonal Antibodies Contain Framework Mutations Predicted From Human Antibody Repertoires
por: Petersen, Brian M., et al.
Publicado: (2021)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Detection of Signal Regulatory Protein α in Saimiri sciureus (Squirrel Monkey) by Anti-Human Monoclonal Antibody
por: de Souza, Hugo Amorim dos Santos, et al.
Publicado: (2017)

Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2018)

Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects
por: Chitnis, Tanuja, et al.
Publicado: (2022)

Antibody Targeting of “Steady-State” Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells
por: Mahnke, Karsten, et al.
Publicado: (2016)

Advances in the Isolation of Specific Monoclonal Rabbit Antibodies
por: Zhang, Zaibao, et al.
Publicado: (2017)

Using Omics Technologies and Systems Biology to Identify Epitope Targets for the Development of Monoclonal Antibodies Against Antibiotic-Resistant Bacteria
por: Martín-Galiano, Antonio J., et al.
Publicado: (2019)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021)

Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2
por: Ahmed, Mahiuddin, et al.
Publicado: (2014)

Characterization of Monoclonal Antibodies Recognizing Citrulline-Modified Residues
por: Chen, Yaqiong, et al.
Publicado: (2022)

Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab
por: Magnus, Clara Luzia, et al.
Publicado: (2022)

Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate
por: Herbener, Peter, et al.
Publicado: (2018)

Bioengineering and computational analysis of programmed cell death ligand-1 monoclonal antibody
por: Kalim, Muhammad, et al.
Publicado: (2022)

Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis
por: Silveira, Pablo A., et al.
Publicado: (2022)

The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass
por: Deveuve, Quentin, et al.
Publicado: (2020)

Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
por: Bohländer, Fabian, et al.
Publicado: (2021)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Generation and Characterization of Anti-AA Amyloid-Specific Monoclonal Antibodies
por: Wall, Jonathan S., et al.
Publicado: (2011)

Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success
por: Jaworski, Juan Pablo, et al.
Publicado: (2017)

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
por: Alfaleh, Mohamed A., et al.
Publicado: (2020)

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
por: Martinez-Navio, José M., et al.
Publicado: (2020)

Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity
por: Chen, Yonglin, et al.
Publicado: (2022)

92R Monoclonal Antibody Inhibits Human CCR9(+) Leukemia Cells Growth in NSG Mice Xenografts
por: Somovilla-Crespo, Beatriz, et al.
Publicado: (2018)

Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates
por: Swanson, Michael D., et al.
Publicado: (2022)

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
por: Vaisman-Mentesh, Anna, et al.
Publicado: (2020)

Targeting regulatory T cells for cardiovascular diseases
por: Wang, Xinting, et al.
Publicado: (2023)

KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors
por: Morales-Estevez, Cristina, et al.
Publicado: (2016)

The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders
por: Häusser-Kinzel, Silke, et al.
Publicado: (2019)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
por: Zhang, Zheng, et al.
Publicado: (2023)

Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies
por: Sun, Ming, et al.
Publicado: (2016)

Prospects for Human Monoclonal Antibodies: A Critical Perspective
por: Brown, Nathaniel A.
Publicado: (1982)

Commentary: Production and Characterization of Monoclonal Antibodies to Human Interleukin 2: Strategy and Tactics
por: Smith, Kendall A.
Publicado: (2015)

Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
por: Lancman, Guido, et al.
Publicado: (2018)

Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection
por: Cerino, Antonella, et al.
Publicado: (2019)

The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies
por: Gurjar, Shalom A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0eh8bo4q2pgm5vmnuu6bffj3q5